Auswahl der wissenschaftlichen Literatur zum Thema „Safety and availability“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Safety and availability" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Safety and availability"
Hanauer, Stephen B. „Balancing drug availability and patient safety“. Nature Clinical Practice Gastroenterology & Hepatology 4, Nr. 3 (März 2007): 117. http://dx.doi.org/10.1038/ncpgasthep0762.
Der volle Inhalt der QuelleHanauer, Stephen B. „Balancing drug availability and patient safety“. Nature Clinical Practice Nephrology 3, Nr. 4 (April 2007): 177. http://dx.doi.org/10.1038/ncpgasthep0762x.
Der volle Inhalt der QuelleGuarro, Sergio B. „Reliability, availability, maintainability and safety assessment“. Reliability Engineering & System Safety 43, Nr. 3 (Januar 1994): 331–32. http://dx.doi.org/10.1016/0951-8320(94)90038-8.
Der volle Inhalt der QuelleCheng, Allen C., und Ken D. Winkel. „Antivenom efficacy, safety and availability: measuring smoke“. Medical Journal of Australia 180, Nr. 1 (Januar 2004): 5–6. http://dx.doi.org/10.5694/j.1326-5377.2004.tb05763.x.
Der volle Inhalt der QuelleSimpson, Ken. „Specifying Availability/Reliability Figures for Safety Systems“. Safety and Reliability 10, Nr. 2 (Juni 1990): 6–14. http://dx.doi.org/10.1080/09617353.1990.11690561.
Der volle Inhalt der QuelleBoukef, K. „Overall strategy for blood safety and availability“. ISBT Science Series 1, Nr. 1 (September 2006): 1–2. http://dx.doi.org/10.1111/j.1751-2824.2006.00001.x.
Der volle Inhalt der QuelleVanderperre, E. J. „Point availability of a robot-safety device“. Operations Research Letters 28, Nr. 3 (April 2001): 143–48. http://dx.doi.org/10.1016/s0167-6377(01)00056-6.
Der volle Inhalt der QuelleHoussin, Remy, und Amadou Coulibaly. „Safety-based availability assessment at design stage“. Computers & Industrial Engineering 70 (April 2014): 107–15. http://dx.doi.org/10.1016/j.cie.2014.01.005.
Der volle Inhalt der QuelleMeckstroth, Steven, Michael Schwartz und Naurang Agrawal. „NSAIDs Safety Implications of Over-the-Counter Availability“. Drug Safety 7, Nr. 4 (1992): 241–44. http://dx.doi.org/10.2165/00002018-199207040-00001.
Der volle Inhalt der QuelleAnasetti, Claudio, Effie W. Petersdorf, Paul J. Martin, Ann Woolfrey und John A. Hansen. „Improving availability and safety of unrelated donor transplants“. Current Opinion in Oncology 12, Nr. 2 (März 2000): 121–26. http://dx.doi.org/10.1097/00001622-200003000-00004.
Der volle Inhalt der QuelleDissertationen zum Thema "Safety and availability"
Asanga, P. M. „Availability and safety study of an oil refinery“. Thesis, University of Bradford, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.379034.
Der volle Inhalt der QuelleWhipp, Alexander R. „Youth Farm Safety: Identification of Common Tasks and Availability of Safety and HealthTeaching Resources“. The Ohio State University, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=osu152414759731944.
Der volle Inhalt der QuelleGhafghazi, Hamidreza. „Privacy-Preserving Location-Aware Data Availability and Access Authorization in Public Safety Broadband Networks“. Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/36006.
Der volle Inhalt der QuelleThomaidis, Thomas Vassiliou. „Incorporation of flexibility, reliability, availability, maintenance and safety aspects in process operations and design“. Thesis, University of London, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.283179.
Der volle Inhalt der QuelleBotha, Barend HJ. „Systematic review: Availability, effectiveness and safety of assisted reproductive techniques in Sub-Saharan Africa“. Master's thesis, University of Cape Town, 2018. http://hdl.handle.net/11427/29315.
Der volle Inhalt der QuelleSevene, Esperança Júlia Pires. „Availability and safety use of drugs in vulnerable populations:the case of pregnant woman in developing countries“. Doctoral thesis, Universitat de Barcelona, 2009. http://hdl.handle.net/10803/2282.
Der volle Inhalt der QuelleThe need of a special protection to those with diminished autonomy is a common requirement to all codes. Pregnant women are defined as a vulnerable population because of the potential risk of harm of the foetus. Apart from the foetal risk, pregnant women in developing countries have additional potential for vulnerability, as in most of the cases they are economically or/and educationally disadvantaged individuals. Their generally low level of education may put them in a difficult situation to fully understand consent forms and the risk-benefit assessment provided by the researchers.
In recent years, the evidence-based medicine has been an important international goal. Mechanisms to support the use of research-based evidence in developing health policy are being promoted. The research must be sensitive to the potential for vulnerability when designing evidence-based trials and they have to assure that the vulnerable population is being protected.
With the intention to protect the vulnerable population, some groups such as pregnant women have being traditionally excluded from clinical trials. As a result of this exclusion, pregnant women are being exposed to medicines in situations where no evidence-based information is available on efficacy and safety. They are deprived of the benefits of treatment in order to be protected themselves and their offspring from an unknown risk. Although is very clear that protection of a vulnerable population, particularly the pregnant women, is mandatory in the design of any trial, the challenges of the implementation of this principle should be taken into account in order to not increase the gap between the introduction of a pharmaceutical product in the market and the availability of safety information for its use in pregnancy.
In developing countries maternal mortality is an important public health problem. Most maternal deaths occur in the poorest countries particularly in Sub-Saharan Africa. In Mozambique the rate could be between 408-1000 per 100 000 live births according to the source of information. Several studies have addressed different causes of maternal mortality in Africa, eclampsia and malaria being part of the five most reported.
There is strong evidence of the effectiveness of magnesium sulphate (MGSO4) in women with pre-eclampsia and eclampsia but the drug is not available in some countries. The example of MgSO4 has being used to describe failure in translating results of research into policy and/or practice.
For malaria treatment few drugs were considered effective and safe for use during pregnancy including chloroquine, sulphadoxine-pyrimethamine and quinine. The information on safety comes from a long experience of use. The emergency of resistance of P. falciparum to these drugs is limiting its use in most of endemic areas. The artemisinin derivatives are being strongly recommended to be used in combination with other antimalarial drugs. Preclinical studies have consistently shown that artemisinin and its derivatives are embryolethal and teratogenic in animals. Current available information is not adequate to extrapolate the results in animals to humans.
Limited data on the safety profile of antimalarial drugs during pregnancy is a challenge. Nowadays these drugs are used in pregnant women based on retrospective cumulative risk-benefit assessment. Mechanisms of prospectively monitoring the drugs use are required to protect pregnant women from the potential risk.
The aim of this thesis is to describe the (un)availability of drugs and their reasons, as well as, the (un)availability of safety information on drugs needed to be used during pregnancy in Southern Africa, and to propose mechanisms to effectively monitor drug safety in pregnancy in developing countries.
In order to achieve this objective four studies were performed. In the first study a qualitative case-study based on interviews and bibliographic review was performed in Mozambique and Zimbabwe. Factors affecting the (un)availability of MgSO4 were assessed. This study showed that research evidence regarding the effectiveness of MgSO4 for the treatment of eclampsia and pre-eclampsia, was widely known in the study countries. However, the registration, approval, acquisition and distribution of MgSO4, and hence its availability to clinicians, was affected by market and systems failures. With this study we concluded that the low cost of magnesium sulphate, as well as the mechanisms through which it is procured, means that market forces alone cannot be relied upon to ensure its availability. Governments and international organizations must be prepared to intervene to ensure the wide availability of low cost, effective drugs critical to improving public health in Africa.
The second and the third studies shown that antimalarial drugs are being used in pregnant women even without information on its safety profile in this particular group. Robust safety monitoring systems are clearly needed in developing countries to accompany the deployment of new drugs, especially those with a potential teratogenic risk.
The fourth study showed that spontaneous reporting system may be a tool for drug safety monitoring. This system could be used to increase health care providers' and patients' awareness of possible ADRs, and to develop a culture to report these reactions. Spontaneous reporting and pregnancy registries were presented as examples of mechanisms that could and should be in place.
Recommendations on how these systems could be effectively implemented in resource constrained countries were also presented.
All these studies suggest that the definition of vulnerability of pregnant women in developing countries should not be restricted to the potential risk of harm of the foetus (harm-based definition) or to the difficulty of fully understanding consent forms (consent-based definitions). Women are also vulnerable because of the high risk of dying from any cause related to or aggravated by the pregnancy. The implementation of these ethic principles need to take into account the urgent need to implement effective and safe drugs targeted to reduce the burden of maternal morbidity and mortality.
La investigación relativa a los seres humanos debe realizarse dentro de unos estándares que promuevan la protección de sus derechos. Varios códigos han sido desarrollados y todos ellos coinciden unánimemente en los siguientes principios éticos: el respeto por las personas, la beneficencia y la justicia. La realización de estos principios debe asegurar la dignidad, los derechos, la seguridad y el bienestar de los participantes en una investigación biomédica sean preservados.
La necesidad de una protección especial hacia aquellos seres cuya autonomía sea limitada es un requerimiento común para todos los códigos. Las mujeres embarazadas están definidas como un grupo de población vulnerable dado el riesgo potencial de causar daño al feto. Además del riesgo para el feto, las mujeres embarazadas en los países en desarrollo son potencialmente más vulnerables, y suelen contar con desventajas a nivel económico y/o educativo. Su nivel de educación, por lo general bajo, les pone en una situación difícil, dificultando la comprensión de los formularios de consentimiento y la evaluación del riesgo-beneficio que prestan los investigadores.
En los últimos años, la medicina basada en la evidencia ha sido una meta muy importante a nivel internacional. Se están promoviendo mecanismos para respaldar el uso de la evidencia científica para la definición de política de desarrollo de la salud. La investigación debe ser sensible a la vulnerabilidad potencial cuando se diseñan ensayos basados en la evidencia. Además, se debe asegurar que la población vulnerable esté siendo protegida.
Con la intención de proteger a esa población vulnerable, algunos grupos como los de mujeres embarazadas han sido tradicionalmente excluidos de los ensayos clínicos. Como resultado de esta exención, algunas mujeres embarazadas están siendo expuestas a medicamentos de los que no hay información basada en la evidencia en cuanto a su eficacia y seguridad. Este hecho las priva de los beneficios del tratamiento que debería protegerlas, a ellas y sus hijos, de un riesgo desconocido. Aunque está muy claro que proteger a una población vulnerable, particularmente a las mujeres embarazadas, es obligatorio en el diseño de un ensayo clínico, los retos de la implementación de este principio no deberían aumentar el vacío entre la introducción de un producto farmacéutico en el mercado y la disponibilidad de información sobre su seguridad para uso en el embarazo.
En los países en vías de desarrollo la mortalidad materna es un problema importante de salud pública. La mayoría de muertes maternas ocurren en los países más pobres, particularmente en África Subsahariana. En Mozambique el índice puede ser entre 408-1000 por 100000 nacidos vivos, dependiendo de la fuente de información. Diferentes estudios han señalado diversas causas de mortalidad materna en África, encontrándose la eclampsia y la malaria entre las cinco primeras.
Existe una gran evidencia de la eficacia del sulfato de magnesio (MGSO4) en mujeres con pre-eclampsia y eclampsia, sin embargo el fármaco no está disponible en algunos países. El ejemplo del sulfato de magnesio se ha utilizado para describir el fracaso en el traslado de los resultados de la investigación a la práctica y/o política.
Para el tratamiento de la malaria, se consideró seguro el uso durante el embarazo de algunos fármacos incluyendo cloroquina, sulfadoxinapirimetamina y quinina. La información sobre seguridad responde a una gran experiencia de uso. El aumento de resistencia de P. falciparum a estos fármacos está limitando su uso en la mayoría de las zonas endémicas. Actualmente se está recomendando el uso de los derivados de la artemisinina en combinación con otros fármacos antimaláricos. Los estudios preclínicos han mostrado sistemáticamente que la artemisina y sus derivados son embrioletales y teratogénicos en animales. La información disponible hasta la fecha no es adecuada para extrapolar los resultados de los animales a los humanos.
Los datos limitados en el perfil de seguridad de los fármacos antimaláricos durante el embarazo constituyen un desafío. Hoy en día, estos fármacos se usan en mujeres embarazadas basándose en una valoración retrospectiva acumulativa de riesgo-beneficio. Se necesitarían mecanismos de monitorización prospectiva del uso de los fármacos para proteger a las mujeres de su riesgo potencial.
El objetivo de esta tesis es el de describir la disponibilidad o no disponibilidad de los fármacos y sus razones; describir la disponibilidad o no disponibilidad de información sobre la seguridad de estos fármacos que son de uso necesario en el sureste de África. Se pretende también proponer mecanismos efectivos para monitorizar la seguridad de los fármacos en el embarazo en los países en desarrollo.
Para alcanzar estos objetivos se llevaron a cabo cuatro estudios. El primero consistía en un estudio cualitativo de casos basados en entrevistas y en una revisión bibliográfica en Mozambique y Zimbawe. Se evaluaron los factores que afectaban a la disponibilidad o no disponibilidad del sulfato de magnesio. El estudio mostró que la evidencia científica respecto a la eficacia del sulfato de magnesio para el tratamiento de la eclampsia y la pre-eclampsia fue ampliamente conocida en los países del estudio. Sin embargo, el registro, aprobación, adquisición y distribución del sulfato de magnesio y como consecuencia, su disponibilidad para los médicos se vio afectada por fallos de mercado y de sistema. Este estudio concluye que el bajo coste del sulfato de magnesio, así como el mecanismo a través del cual se obtiene, significa que las fuerzas del mercado por si solas no pueden asegurar su disponibilidad. Los gobiernos y las organizaciones internacionales deben estar preparados para intervenir y para asegurar una amplia disponibilidad de fármacos efectivos de bajo coste, críticos para mejorar la salud pública en África.
El segundo y tercer estudio mostraron que los fármacos antimaláricos se están usando en mujeres embarazadas sin contar con información sobre su perfil de seguridad en este grupo particular. Se necesita claramente una monitorización fuerte y segura en los países en vías de desarrollo para acompañar el despliegue de los nuevos fármacos, especialmente aquellos que conllevan un potencial riesgo teratogénico.
El cuarto estudio mostró que el sistema de notificación espontánea puede ser una herramienta para la monitorización de la seguridad de los fármacos. Este sistema se podrá usar para incrementar la consciencia en proveedores de salud y en enfermos sobre las posibles reacciones adversas de fármacos. Ello permitirá desarrollar una cultura de notificación de estas reacciones. La notificación espontánea y los registros de embarazo se presentaron como ejemplos de mecanismos que podrían y deberían ser implementados. Las recomendaciones de cómo estos sistemas podrían ser implementados de forma efectiva en países con recursos limitados también fueron presentadas.
Todos estos estudios sugieren que la definición de vulnerabilidad de las mujeres embarazas en los países en desarrollo no se puede restringir a causa del riesgo potencial de daño al feto, o debido a la dificultad de entender por completo los formularios de consentimiento. También son vulnerables por el riesgo elevado de morir por alguna causa relacionada o agravada por el embarazo. La implementación de estos principios éticos necesita tener en cuenta la necesidad de implementar fármacos diana efectivos y seguros para reducir la mortalidad y morbilidad materna.
Olivier, Anna-Louise. „Psychological conditions that mediate between job demands and resources, and work engagement / Anna-Louise Olivier“. Thesis, North-West University, 2006. http://hdl.handle.net/10394/1401.
Der volle Inhalt der QuelleKarimi, Hossein. „QUANTITATIVE ANALYSIS OF THE IMPACT OF CRAFT LABOR AVAILABILITY ON CONSTRUCTION PROJECT PERFORMANCE“. UKnowledge, 2017. http://uknowledge.uky.edu/ce_etds/56.
Der volle Inhalt der QuelleMeng, Huixing. „Modeling Patterns for Performance Analysis of Production and Safety Systems in Process Industry“. Thesis, Université Paris-Saclay (ComUE), 2017. http://www.theses.fr/2017SACLX074/document.
Der volle Inhalt der QuelleProduction and safety systems are crucial in the process industry. Their performances affect significantly the industry interests. These systems have common behaviors. Such behaviors can be captured in models via modeling patterns. By reusing modeling patterns, the modeling process can be simplified and made more efficient.In this thesis, we propose a versatile set of modeling patterns. They are classified according to their purpose, which reflects what a modeling pattern works for. Modeling patterns are exhibited as a catalog. Based on reviewing numerous production and safety systems, twenty-four (24) modeling patterns are introduced. Each pattern is illustrated with a set of structured items. We propose a pattern-based methodology for performance analysis of production and safety systems.To test the applicability of proposed modeling patterns, we conducted experimental studies on a set of production and safety systems. All systems are extracted from the literature. These systems are declared to cover most of modeling difficulties. Comparisons are performed between the results obtained using modeling patterns and those reported in the literature
Basharat, Salma. „Proactive Emergency Preparedness in the Barents Sea“. Thesis, Norges teknisk-naturvitenskapelige universitet, Institutt for produksjons- og kvalitetsteknikk, 2012. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-18401.
Der volle Inhalt der QuelleBücher zum Thema "Safety and availability"
Reliability, availability, maintainability, and safety assessment. Chichester: J. Wiley, 1992.
Den vollen Inhalt der Quelle findenVillemeur, Alain. Reliability, availability, maintainability and safety assessment. Chichester: John Wiley and Sons, 1992.
Den vollen Inhalt der Quelle findenFEDERAL AVIATION ADMINISTRATION. Takeoff safety training aid announcement of availability. Washington, D.C. (800 Independence Ave., S.W., Washington 20591): U.S. Dept. of Transportation, Federal Aviation Administration, 1994.
Den vollen Inhalt der Quelle findenKumar, Uday, Alireza Ahmadi, Ajit Kumar Verma und Prabhakar Varde, Hrsg. Current Trends in Reliability, Availability, Maintainability and Safety. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23597-4.
Der volle Inhalt der QuelleCosper, Donna K. Availability of passenger safety information for improved survival in aircraft accidents. Washington, D.C: U.S. Department of Transportation, Federal Aviation Administration, Office of Aerospace Medicine, 2004.
Den vollen Inhalt der Quelle findenUnited States. National Aeronautics and Space Administration., Hrsg. Electronic availability of microgravity experiments safety and integration requirements documents. [Washington, D.C.]: National Aeronautics and Space Administration, 1995.
Den vollen Inhalt der Quelle findenservice), SpringerLink (Online, Hrsg. Handbook of Reliability, Availability, Maintainability and Safety in Engineering Design. London: Springer London, 2009.
Den vollen Inhalt der Quelle findenSchneeweiss, Winfrid G. Reliability modeling: (modeling in the fields of dependability, availability, maintainability, and safety engineering). Hagen: LiLoLe-Verlag, 2001.
Den vollen Inhalt der Quelle findenAviation safety: Enhanced oversight and improved availability of risk-based data could further improve safety : report to congressional committees. Washington, D.C.]: U.S. Govt. Accountability Office, 2011.
Den vollen Inhalt der Quelle findenFaulin, Javier. Simulation Methods for Reliability and Availability of Complex Systems. London: Springer-Verlag London, 2010.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Safety and availability"
Aggarwal, K. K. „Maintainability and Availability“. In Topics in Safety, Reliability and Quality, 153–77. Dordrecht: Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-1928-3_8.
Der volle Inhalt der QuelleBaro, Sylvain. „A High-Availability Safety Computer“. In Security of Computer Architectures, 425–46. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118600696.ch11.
Der volle Inhalt der QuelleLydersen, Stian. „Periodically Overhauled Systems Availability“. In Probabilistic Safety Assessment and Management ’96, 172–77. London: Springer London, 1996. http://dx.doi.org/10.1007/978-1-4471-3409-1_28.
Der volle Inhalt der Quelle(Ravi) Ravishankar, T. J., Lionel D. Bates und John M. Romagnino. „Setpoint Design Impact on Availability“. In Probabilistic Safety Assessment and Management, 3678–84. London: Springer London, 2004. http://dx.doi.org/10.1007/978-0-85729-410-4_588.
Der volle Inhalt der QuelleRedmill, F., und K. Boot-Handford. „Another Dimension of Availability“. In Achieving Safety and Reliability with Computer Systems, 276–84. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3461-0_23.
Der volle Inhalt der QuelleRoth, Dana L. „CHAPTER 7. Commercial Availability, Safety, and Hazards“. In Chemical Information for Chemists, 184–205. Cambridge: Royal Society of Chemistry, 2014. http://dx.doi.org/10.1039/9781782620655-00184.
Der volle Inhalt der QuelleTimpanaro, Juan Pablo, Isabelle Chrisment und Olivier Festor. „Improving Content Availability in the I2P Anonymous File-Sharing Environment“. In Cyberspace Safety and Security, 77–92. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-35362-8_8.
Der volle Inhalt der QuelleZio, E., M. Marella und L. Podofillini. „Availability Assessment of Multi-State Systems with Operational Dependence“. In Probabilistic Safety Assessment and Management, 914–19. London: Springer London, 2004. http://dx.doi.org/10.1007/978-0-85729-410-4_148.
Der volle Inhalt der QuelleSignoret, Jean-Pierre, und Alain Leroy. „Extensions to Production Availability and Functional Safety Analyses“. In Springer Series in Reliability Engineering, 121–36. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-64708-7_6.
Der volle Inhalt der QuelleMorant, Amparo, Anna Gustafson und Peter Söderholm. „Safety and Availability Evaluation of Railway Signalling Systems“. In Lecture Notes in Mechanical Engineering, 303–16. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-23597-4_22.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Safety and availability"
Wang, Peng, und Yan Bai. „Safety and availability optimization of safety instrumented system“. In 2011 9th International Conference on Reliability, Maintainability and Safety (ICRMS 2011). IEEE, 2011. http://dx.doi.org/10.1109/icrms.2011.5979330.
Der volle Inhalt der QuelleCossy, Melanie. „Software Safety Architecture to Fulfill Increased Safety and Availability Requirements“. In SAE 2003 World Congress & Exhibition. 400 Commonwealth Drive, Warrendale, PA, United States: SAE International, 2003. http://dx.doi.org/10.4271/2003-01-0102.
Der volle Inhalt der QuelleCarlucci, Elisa, und Leonardo Tognarelli. „e-LNG Plant Availability Estimation“. In Proceedings of the 29th European Safety and Reliability Conference (ESREL). Singapore: Research Publishing Services, 2019. http://dx.doi.org/10.3850/978-981-11-2724-3_0733-cd.
Der volle Inhalt der QuelleHun, Kok Ping, und Khairul Nizam Baharim. „Predictive Modelling for Asset Availability using Artificial Intelligence“. In 33rd European Safety and Reliability Conference. Singapore: Research Publishing Services, 2023. http://dx.doi.org/10.3850/978-981-18-8071-1_p050-cd.
Der volle Inhalt der QuelleZheng, Heng, und Liming Ren. „Availability analysis of satellite constellation“. In 2009 8th International Conference on Reliability, Maintainability and Safety (ICRMS 2009). IEEE, 2009. http://dx.doi.org/10.1109/icrms.2009.5270198.
Der volle Inhalt der QuelleSalmi, Louis-Rachid, Eric Tellier und Bruno Simonnet. „PW 2149 Issues in data availability and results in two international surveys on drowning“. In Safety 2018 abstracts. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/injuryprevention-2018-safety.437.
Der volle Inhalt der QuelleSackx, Eva, und Antonio Longhi. „An Integrated Reliability, Availability, and Maintainability Approach for Metro Systems“. In 33rd European Safety and Reliability Conference. Singapore: Research Publishing Services, 2023. http://dx.doi.org/10.3850/978-981-18-8071-1_p541-cd.
Der volle Inhalt der QuelleAkrouche, Joanna, Mohamed Sallak, Eric Châktelet, Fahed Abdallah und Hiba Haj Chhadâ. „Methodology for Imprecise Availability Computing and Optimization“. In Proceedings of the 29th European Safety and Reliability Conference (ESREL). Singapore: Research Publishing Services, 2019. http://dx.doi.org/10.3850/978-981-11-2724-3_0599-cd.
Der volle Inhalt der QuelleZhao, Guangyan, Yufeng Sun, Weiwei Hu und Tong Qin. „Study on constellation per-slot availability“. In 2013 International Conference on Quality, Reliability, Risk, Maintenance, and Safety Engineering (QR2MSE). IEEE, 2013. http://dx.doi.org/10.1109/qr2mse.2013.6625582.
Der volle Inhalt der QuelleBrunink, Marc, Martin Susskraut und Christof Fetzer. „Boundless memory allocations for memory safety and high availability“. In Networks (DSN). IEEE, 2011. http://dx.doi.org/10.1109/dsn.2011.5958203.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Safety and availability"
Agency, Food Standards. The impact of labour shortages on UK food availability and safety. Food Standards Agency, November 2023. http://dx.doi.org/10.46756/sci.fsa.oac747.
Der volle Inhalt der QuelleHuysamen, Kirsten, Murray Collins und Alice Wardle. MIS070 GSR Technical study to to assess and develop performance requirements and test protocols for driver availability monitoring systems. TRL, Dezember 2021. http://dx.doi.org/10.58446/tmfa9969.
Der volle Inhalt der QuelleCook, Stephen, und Loyd Hook. Developmental Pillars of Increased Autonomy for Aircraft Systems. ASTM International, Januar 2020. http://dx.doi.org/10.1520/tr2-eb.
Der volle Inhalt der QuelleSrivastava, Shilpi, Jeremy Allouche, Roz Price und Tina Nelis. Bringing WASH into the Water–Energy–Food Nexus in Humanitarian Settings. Institute of Development Studies (IDS), Februar 2022. http://dx.doi.org/10.19088/ids.2022.006.
Der volle Inhalt der QuelleWiley, Jenny L., Camille K. Gourdet und Brian F. Thomas. Cannabidiol: Science, Marketing, and Legal Perspectives. RTI Press, April 2020. http://dx.doi.org/10.3768/rtipress.2020.op.0065.2004.
Der volle Inhalt der QuelleHedrick und Jacobs. PR-457-14201-R01 Variable Natural Gas - Composition Effects and Control Methods for Two-Stroke Engines. Chantilly, Virginia: Pipeline Research Council International, Inc. (PRCI), Juni 2015. http://dx.doi.org/10.55274/r0010027.
Der volle Inhalt der QuelleZandiatashbar, Ahoura, Jochen Albrecht und Hilary Nixon. A Bike System for All in Silicon Valley: Equity Assessment of Bike Infrastructure in San José, CA. Mineta Transportation Institute, Oktober 2023. http://dx.doi.org/10.31979/mti.2023.2162.
Der volle Inhalt der QuelleLuo, Hao, Ricardo Chahine, Arianna Rambaram, Elizabeth Theresa Rosenzweig, Konstantina Gkritza und Hua Cai. Assessing the Travel Demand and Mobility Impacts of Transformative Transportation Technologies in Indiana. Purdue University, 2023. http://dx.doi.org/10.5703/1288284317374.
Der volle Inhalt der QuelleToloo, Sam, Ruvini Hettiarachchi, David Lim und Katie Wilson. Reducing Emergency Department demand through expanded primary healthcare practice: Full report of the research and findings. Queensland University of Technology, Januar 2022. http://dx.doi.org/10.5204/rep.eprints.227473.
Der volle Inhalt der QuelleYoozbashizadeh, Mahdi, und Forouzan Golshani. Robotic Parking Technology for Congestion Mitigation and Air Quality Control Around Park & Rides. Mineta Transportation Institute, Juni 2021. http://dx.doi.org/10.31979/mti.2021.1936.
Der volle Inhalt der Quelle